H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $29.58
    +0.74 (+2.57%)

    Market Cap: $6.73B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(13/23)
    Avg Surprise
    -14.25%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.07
    Range$-0.01 - $0.20
    9 analysts
    EPS RevisionsNo revisions (7d)
    1
    8
    30d
    EPS Estimate Drift
    90d ago$0.12+66.2%
    60d ago$0.06-19.9%
    30d ago$0.06-19.9%
    7d ago$0.07-13.2%
    Current$0.07
    Revenue Consensus
    $894M
    Range$890M - $902M
    10 analysts
    Dec 31, 2026
    EPS Consensus$-0.50
    Range$-0.97 - $-0.07
    11 analysts
    Revenue Consensus
    $960M
    Range$898M - $1.1B
    14 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.50---
    Sep 26EST
    		-$0.07---
    Jun 26
    		$-0.10$-0.07-42.86%Miss-134.5%
    Mar 26
    		$-0.19$0.13-246.15%Miss-167.9%
    Dec 25
    		$0.22$0.19+15.79%Beat+100.0%
    Sep 25
    		$0.28$0.23+21.74%Beat-34.9%
    Jun 25
    		$0.29$0.23+26.09%Beat+81.2%
    Mar 25
    		$0.28$0.23+21.74%Beat+180.0%
    Dec 24
    		$0.11$0.22-49.43%Miss+1000.0%
    Sep 24
    		$0.43$0.15+186.67%Beat+616.7%
    Jun 24
    		$0.16$0.13+23.08%Beat+220.0%
    Mar 24
    		$0.10$0.08+25.00%Beat+233.3%
    Dec 23
    		$0.01$-0.02+150.00%Beat+120.0%
    Sep 23
    		$0.06$0.05+20.00%Beat+166.7%
    Jun 23
    		$0.05$0.03+66.67%Beat+150.0%
    Mar 23
    		$0.03$0.02+50.00%Beat+137.5%
    Dec 22
    		$-0.05$-0.07+28.57%Beat+66.7%
    Sep 22
    		$-0.09$-0.06-50.00%Miss+10.0%
    Jun 22
    		$-0.10$-0.06-66.67%Miss-11.1%
    Mar 22
    		$-0.08$-0.06-33.33%Miss+71.4%
    Dec 21
    		$-0.15$-0.07-114.29%Miss-114.3%
    Sep 21
    		$-0.10$-0.06-66.67%Miss-75.1%
    Jun 21
    		$-0.09$-0.06-50.00%Miss-22.1%
    Mar 21
    		$-0.28$-0.07-300.00%Miss-660.0%
    Dec 20
    		$-0.07N/A+56.25%Beat-333.3%
    Sep 20
    		$-0.06N/AN/ABeat-385.5%
    Jun 20
    		$-0.07N/AN/ABeat+69.6%
    Mar 20
    		$0.05N/AN/ABeat+118.6%
    Dec 19
    		$0.03N/AN/ABeat+111.2%
    Sep 19
    		$0.02N/AN/ABeat-
    Jun 19
    		$-0.24$0.00N/AMiss-
    Mar 19
    		$-0.27$0.00N/AMiss-
    Dec 18
    		$-0.27$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio140.86EV/EBITDA205.86x
    Price/FCF111.22xFCF Yield0.90%
    Profitability
    Profit Margin-5.51%Operating Margin-12.80%
    ROE-32.00%ROIC-8.40%
    Financial Health
    Debt/Equity4.21xInterest CoverageN/A
    Current Ratio0.93xQuick Ratio0.87x
    Trading Statistics
    Beta2.42Avg Volume12.87M
    52-Week High$65.3052-Week Low$13.74

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$30.69
    SMA 20$30.48
    SMA 50$31.99
    SMA 200$28.55
    EMA 10$30.35
    EMA 20$30.49
    EMA 50$30.51
    EMA 200$31.35

    MACD

    Line: -0.21Signal: -0.21Hist: 0.00

    ADX

    ADX: 11.0+DI: 18.6-DI: 21.0

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down12.0
    PSAR$34.34

    Bollinger Bands

    Upper Band$33.73
    Lower Band$27.24
    %B Position2126%(Upper)
    Band Width0.36

    RSI (14-Day)

    Neutral
    47.5

    Momentum Oscillators

    Stoch %K37.4
    Stoch %D42.8
    Williams %R-68.9
    ROC (10d)3.4%
    Momentum0.97
    CCI (20d)-65.9
    MFI (14d)42.5

    Volatility Measures

    ATR (14d)$2.33(7.9%)
    StdDev (20d)1.62
    Hist Vol90.5%(High)

    Volume Flow

    VWAP$29.34
    OBV306.1M
    AD Line-291.7M
    CMF (20d)0.015

    Volume Metrics

    Avg Vol (20d)12.8M
    Vol Ratio0.6x
    VWMA (20d)$30.64

    Pivot Points

    R3$33.53
    R2$32.47
    R1$30.65
    Pivot Point$29.59
    S1$27.77
    S2$26.71
    S3$24.89

    Advanced Oscillators

    TSI-2.03
    Ultimate Osc45.4
    KST-32.33

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$753.21M$608.10M$617.82M$598.98M$544.83M$586.01M$481.14M$401.56M$315.65M$278.17M$246.62M$226.70M
    Cost of Revenue$272.41M$211.32M$173.38M$156.92M$128.64M$155.32M$111.60M$83.67M$59.03M$49.08M$42.56M$39.39M
    Gross Profit$480.80M$396.79M$444.44M$442.06M$416.20M$430.69M$369.54M$317.89M$256.61M$229.09M$204.06M$187.31M
    Operating Expenses$578.00M$475.11M$435.25M$430.25M$389.47M$372.79M$350.94M$295.51M$245.58M$219.19M$204.46M$195.86M
    R&D$54.90M$46.94M$40.96M$40.58M$37.85M$29.91M$23.75M$21.09M$18.65M$15.32M$13.40M$12.27M
    SG&A$165.38M$109.67M$76.17M$80.68M$67.27M$48.61M$48.03M$44.62M$40.55M$34.57M$32.32M$35.91M
    Operating Income$-97,192,000$-78,323,000$9.19M$11.81M$26.72M$57.90M$18.60M$22.37M$11.03M$9.90M$-400,000$-8,554,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$23.23M$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-92,633,000$-101,551,000$18.35M$12.22M$32.85M$60.49M$22.29M$23.59M$13.42M$12.40M$2.20M$-6,916,000
    Income Tax Expense$-6,343,000$-9,436,000$-2,248,000$-3,551,000$-9,652,000$11.01M$-3,734,000$-51,995,000$127,000$1.27M$951,000$651,000
    Net Income$-86,290,000$-92,115,000$20.60M$15.77M$42.51M$49.48M$26.02M$75.59M$13.30M$11.13M$1.25M$-7,567,000
    EBITDA$-61,119,000$-78,139,000$37.47M$31.38M$44.00M$68.08M$27.44M$26.82M$15.86M$14.33M$3.20M$-6,070,000
    EBIT$-92,455,000$-101,551,000$18.35M$12.22M$32.85M$60.49M$22.29M$23.59M$13.42M$12.40M$2.20M$-6,916,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HIMS

    News

    Kaplan Fox Notifies Investors of Hims & Hers Health, Inc. (NYSE: HIMS) of an Investigation Into Potential Securities Law Violations

    Kaplan Fox & Kilsheimer LLP has initiated an investigation into potential securities law violations by Hims & Hers Health, Inc. (NYSE: HIMS). This investigation follows a lawsuit filed by the FTC, California, and Utah alleging that Hims & Hers failed to clearly disclose subscription charges, made it difficult to cancel, and misled consumers about the privacy of their health information, which reportedly led to a 14.73% drop in the company's stock price. Kaplan Fox is urging affected investors to contact them for more information regarding this investigation.

    The National Law Review•8/25/26•
    Bearish

    Hims & Hers Health, Inc. Investigated by the Portnoy Law Firm

    The Portnoy Law Firm has launched an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities fraud. The investigation stems from allegations that Hims misled consumers by charging them for unwanted prescription medication subscriptions without explicit consent and falsely representing free consultations. This alleged deceptive conduct led to a sharp decline in Hims' stock price, causing significant losses for investors, for whom the firm may file a class action lawsuit.

    GlobeNewswire•8/25/26•
    Bearish

    Bragar Eagel & Squire, P.C. is Investigating Hims & Hers

    Bragar Eagel & Squire, P.C., a stockholder rights law firm, is investigating potential claims against Hims & Hers Health, Inc. following a lawsuit filed by the FTC and California/Utah. The lawsuit alleges that Hims & Hers failed to clearly disclose prescription charges, made it difficult for consumers to cancel subscriptions, and misled them about privacy by sharing health information with third parties. This news led to a 14.73% drop in Hims & Hers stock on July 29, 2026.

    GlobeNewswire•8/21/26•
    Bearish

    Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

    Kaplan Fox & Kilsheimer LLP is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities violations after the Federal Trade Commission and others sued the company. The lawsuit alleges Hims & Hers failed to clearly disclose prescription charges, made it difficult to cancel subscriptions, and shared consumers' health information with third parties. Following this news, Hims & Hers stock price fell by 14.73%.

    NewMediaWire•8/21/26•
    Bearish

    HIMS Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. Investors to Contact the Firm

    Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws by Hims & Hers Health, Inc. following a lawsuit filed by the Federal Trade Commission (FTC). The FTC accuses HIMS of sharing customers' medical information with third-party advertisers, causing HIMS's stock price to drop over 14%. The law firm is encouraging investors who experienced losses to contact them to discuss their legal rights.

    NewMediaWire•8/21/26•
    Bearish

    Frequently Asked Questions About HIMS

    Does HIMS pay dividends?
    Hims Hers Health Inc (HIMS) does not currently pay a regular dividend.
    What is HIMS's P/E ratio?
    Hims Hers Health Inc has a price-to-earnings (P/E) ratio of 140.86.
    What is HIMS's market cap?
    Hims Hers Health Inc (HIMS) has a market capitalization of $6.73B with a current stock price of $29.58.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In